Position in ARVN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$649,401
-$203,814 QoQ
Shares Held
78,147
-2.9% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 198 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. ARVN ranks #161 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in ARVN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $649,401 | 78,147 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $853,215 | 80,492 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,034,144 | 87,196 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $846,666 | 99,374 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $751,286 | 102,077 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $640,294 | 91,210 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,684,602 | 87,877 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $2,145,839 | 87,123 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,401,895 | 90,229 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,939,342 | 71,205 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,835,512 | 68,890 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,355,160 | 69,000 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,705,680 | 68,722 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,804,677 | 66,057 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,206,305 | 64,493 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,831,343 | 63,640 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,464,916 | 58,563 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,319,505 | 49,324 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,929,988 | 47,845 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,873,800 | 47,138 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,499,727 | 45,451 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,565,341 | 38,810 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $3,328,576 | 39,192 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $875,387 | 37,077 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,421,156 | 42,372 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,108,290 | 27,501 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||